These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15501349)

  • 1. [Statins and cerebral and cardiovascular risk in elderly people].
    Schlienger JL; Vinzio S; Pradignac A; Grunenberger F; Goichot B
    Rev Med Interne; 2004 Nov; 25(11):801-5. PubMed ID: 15501349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
    Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins-a panacea?].
    Klose G
    Z Kardiol; 2004; 93 Suppl 1():I19-22. PubMed ID: 15022003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M747-50. PubMed ID: 12403804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation.
    Corrao G; Monzio Compagnoni M; Franchi M; Cantarutti A; Pugni P; Merlino L; Catapano AL; Mancia G
    Eur J Intern Med; 2018 Jan; 47():25-31. PubMed ID: 28958460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD.
    Aronow WS
    Geriatrics; 2001 Sep; 56(9):22-5, 28-30. PubMed ID: 11582971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypercholesterolemia in men and women of various age. Part II. The problem of efficacy and safety of statins].
    Preobrazhenskiĭ DV; Sidorenko BA; Pataraia SA; Vyshinskaia ID; Borisenko OV
    Kardiologiia; 2007; 47(11):75-85. PubMed ID: 18260968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins for stroke prevention: disappointment and hope.
    Amarenco P; Tonkin AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia. The evidence supports use of statins.
    Aronow WS
    Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W; Gmiński J
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should receive HMG CoA reductase inhibitors?
    Teo KK; Burton JR
    Drugs; 2002; 62(12):1707-15. PubMed ID: 12149041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering drug therapy in elderly patients.
    Berthold HK; Gouni-Berthold I
    Curr Pharm Des; 2011; 17(9):877-93. PubMed ID: 21418034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.
    Amarenco P; Labreuche J
    Lancet Neurol; 2009 May; 8(5):453-63. PubMed ID: 19375663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins and cerebrovascular disease: new perspectives in stroke prevention].
    Castilla-Guerra L; Fernández-Moreno MC; López-Chozas JM; Jiménez-Hernández MD
    Rev Neurol; 2007 Jan 16-31; 44(2):95-100. PubMed ID: 17236149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.